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Repair of DNA double-strand breaks is crucial for
maintaining genome integrity and is governed by
post-translational modifications such as protein
ubiquitylation. Here, we establish that the deubiqui-
tylating enzyme USP4 promotes DNA-end resection
and DNA repair by homologous recombination.
We also report that USP4 interacts with CtIP and
the MRE11-RAD50-NBS1 (MRN) complex and is
required for CtIP recruitment to DNA damage sites.
Furthermore, we show that USP4 is ubiquitylated
on multiple sites including those on cysteine resi-
dues and that deubiquitylation of these sites re-
quires USP4 catalytic activity and is required for
USP4 to interact with CtIP/MRN and to promote
CtIP recruitment and DNA repair. Lastly, we estab-
lish that regulation of interactor binding by ubiquity-
lation occurs more generally among USP-family
enzymes. Our findings thus identify USP4 as a novel
DNA repair regulator and invoke a model in which
ubiquitin adducts regulate USP enzyme interactions
and functions.
INTRODUCTION
To counteract the deleterious consequences of DNA double-
strand breaks (DSBs) and other DNA lesions, multiple cellular
mechanisms have evolved, collectively termed the DNA damage
response (DDR) (Ciccia and Elledge, 2010; Jackson and Bartek,
2009). The DDR is tightly regulated by reversible post-transla-
tional protein modifications (PTMs). For instance, following DSB
recognition by sensor proteins such as the MRE11-RAD50-
NBS1 (MRN) complex that interacts with CtIP (Sartori et al.,
2007), phosphorylationcascades triggeredby theprotein kinases
ATM,ATR, andDNA-PKcscontrol andcoordinateDSB repair and362 Molecular Cell 60, 362–373, November 5, 2015 ª2015 The Authoassociated events. These events include phosphorylation of his-
tone 2A variant H2AXon serine 139 (to formgH2AX) on chromatin
flankingDSBsites, towhichMDC1 thenbinds (Stucki et al., 2005),
mediating recruitment of factors such as the E3 ubiquitin ligases
RNF8 and RNF168, together with 53BP1 and the BRCA1-A com-
plex, leading to chromatin remodelling in preparation for repair
(Ciccia and Elledge, 2010).
Phosphorylation has been extensively studied in the context of
the DDR for many years. By contrast, how ubiquitylation—the
covalent attachment of the 8.5 kDa protein ubiquitin to sub-
strates—and related events regulate DSB repair and associated
processes has only recently become the focus of intensive
research. Ubiquitin is conjugated to its substrates via an enzy-
matic cascade involving an activating (E1), conjugating (E2)
enzyme, and, in most cases an E3 ubiquitin ligase (Hershko
et al., 1983); and in mammals, ubiquitylation involves two E1s,
more than 35 E2s, and >600 E3 ligases (Clague et al., 2015).
Substrates can be mono-ubiquitylated at more than one site
and/or are polyubiquitylated by polymerization of multiple ubiq-
uitin moieties via one or more of seven internal lysine residues
(Lys-6, Lys-11, Lys-27, Lys-29, Lys-33, Lys-48, and Lys-63)
within ubiquitin or with the ubiquitin amino-terminus (Komander,
2009a). These different linkages lead to ubiquitin chains with
distinct structural features and functions, including those with
well-established roles in the DDR (Ciccia and Elledge, 2010;
Jackson and Durocher, 2013). In recent years, it has become
evident that editing and removal of such ubiquitylations by deu-
biquitylases (DUBs) play crucial roles in regulating ubiquitylation
events and the activities they control.
The human genome encodes 94 putative DUBs, classed into
five groups based on structural features of their catalytic do-
mains (Komander et al., 2009b). We recently carried out a sys-
tematic screen of DUBs for DDR functions, particularly focusing
on DSB repair by non-homologous end-joining (NHEJ) or homol-
ogous recombination (HR) (Nishi et al., 2014). Among others, this
work suggested DSB repair roles for members of the structurally
similar ubiquitin-specific proteases USP4, USP15, and USP11
(Komander et al., 2009b), the latter being a DUB with previously
established DDR roles (Schoenfeld et al., 2004; Wiltshire et al.,rs
2010). Notably, USP4, USP11, and USP15 are implicated in
related cellular events, including TGF-b signaling (Al-Salihi
et al., 2012; Inui et al., 2011; Zhang et al., 2012), raising the pos-
sibility that they might have redundant and/or complementary
DDR functions.
Here, we report that USP4, a DUB with previously reported
links to mitogen-activated protein (MAP) kinase signaling (e.g.,
Zhang et al., 2012), pre-mRNA splicing (Song et al., 2010), and
control of p53 stability (Zhang et al., 2011), regulates DNA repair
and cellular survival upon DSB induction. We also show that
USP4 depletion impairs HR repair by affecting the process of
DNA-end resection. Additionally, we establish that USP4 inter-
acts with CtIP and the MRN complex via its C-terminal insert
domain and that these interactions are subject to a USP4 auto-
regulatory deubiquitylation mechanism. Finally, we provide evi-
dence that this type of control might operate more widely by
showing that interactions between USP15 with SMAD2/3 (Inui
et al., 2011) are subject to USP15 auto-regulation.
RESULTS
USP4 Promotes DSB Repair
We recently showed that the structurally similar proteins USP4,
USP11, and USP15 have DDR roles (Nishi et al., 2014) (see Fig-
ure S1A for their domain features). Focusing on USP4, we found
by neutral comet assays that its depletion from human U2OS
cells by various short-interfering RNA (siRNA) oligonucleotides
(Figure 1A) reduced repair of DSBs induced by the radiomi-
metic chemical phleomycin (Figure 1B; see Figure S1B for con-
trol CtIP and DNA ligase IV depletions). To determine whether
such effects were mediated via USP4 loss, we generated stable
cell lines expressing GFP fused to wild-type USP4 (GFP-USP4
WT) and selected a clone, GFP-USP4 WT(L) (see Figure S1C
for this and other cell lines used in this study), where fusion pro-
tein expression was comparable to endogenous USP4 (see Fig-
ure 1C, lane 4 to compare endogenous and exogenous USP4).
We then treated GFP-USP4 WT(L) cells or control cells express-
ing GFP alone with an siRNA targeting the USP4 coding region
(USP4-2) to deplete both endogenous and GFP-fused USP4 or
with an siRNA targeting the USP4 30 UTR to deplete endogenous
but not exogenous GFP-fused USP4 (Figure 1C). Ensuing comet
analyses (Figure 1D) revealed that, while both siRNAs produced
DSB repair defects in control cells, only the coding-region target-
ing siRNA yielded such a defect in cells expressing GFP-USP4
WT(L). These data thus indicated that GFP-USP4WT expression
complemented DSB repair defects induced by depleting endog-
enous USP4. USP4 depletion also sensitized cells to ionizing
radiation (IR) (Figure 1E; see Figure S1D for depletion of the
NHEJ protein XRCC4), providing additional evidence that
USP4 promotes DNA repair.
Consistent with previous work (Nishi et al., 2014), we found
that stably expressed GFP-fused USP4 WT accumulated at
DNA damage sites generated by laser micro-irradiation (Fig-
ure S1E), suggesting that USP4 functions in proximity to DNA
lesions. By contrast, we did not detect DNA-damage accumula-
tion of GFP-fused U4/U6 recycling protein SART3 (data not
shown), which interacts with USP4 and targets USP4 to its spli-
ceosomal substrate PRP3 (Song et al., 2010). Although thisMolemight be due to detection limitations, these data suggested
that USP4 might exist in multiple complexes and that its roles
in DSB repair might be distinct from its spliceosomal functions.
While it has been reported that overexpressed SART3 causes
nuclear localization of exogenously expressed USP4 (Song
et al., 2010), we found that SART3 depletion from U2OS cells
did not detectably affect the nuclear/cytoplasmic distribution
of endogenous USP4 (data not shown), suggesting that USP4
nuclear targeting might be mediated by multiple mechanisms.
To assess whether USP4 catalytic activity was needed for
effectiveDSB repair,we characterizedU2OScell clones express-
ing similar amounts of USP4WT (referred to asGFP-USP4WT(H))
or GFP fused to catalytically dead USP4 (USP4 CD), where the
catalytic cysteine (Cys-311) was changed to alanine (C311A;
also see Figure S1C for expression levels). We then depleted
endogenousUSP4 fromsuch cells by siRNA treatment (Figure 1F)
and subjected them to neutral comet assays. This showed that
USP4 catalytic activity was required for effective DSB repair (Fig-
ure 1G). Furthermore, during the course of these studies, we
found that cells expressing USP4 CD displayed DSB repair de-
fects even without endogenous USP4 depletion (Figure 1G; see
Figure S1F for equivalent neutral comet assays without siRNA
treatments), suggesting that catalytically dead USP4 behaved in
a dominant-negative manner. Accordingly, U2OS cells express-
ingGFP-USP4CDweremore sensitive to IR than cells expressing
GFP or GFP-USP4 WT (Figure 1H). By co-transfection of FLAG-
epitope-tagged USP4 WT with GFP-USP4 WT or CD constructs,
followed by GFP-immunoprecipitation (IP) and western blot ana-
lyses, we found that USP4molecules interacted with one another
irrespective of catalytic function (Figure 1I). We thus speculate
that USP4 CD exerts its dominant-negative effects, at least in
part via binding to endogenous USP4.
USP4 Functions in DNA-End Resection
Through ensuing studies, we established that USP4 depletion
reduced HR-repair efficiencies in a cell-based assay measuring
chromosomal DSB repair by gene conversion (Figure 2A). Impor-
tantly, these effects were observed despite the siRNA targeting
the USP4 30 UTR having little effect on the combined S/G2-
phase cell population (Figure S2A; although siUSP4-2 reduced
the S/G2 population by 25% compared to the siRNA control,
this is unlikely to account for the 60% reduced HR efficiency).
USP4 depletion also reduced NHEJ as assessed by a random
plasmid integration assay (Figure S2B). Although USP4 involve-
ment in NHEJ will be worth pursuing, our studies focused on its
impact on HR and related events. Importantly, in line with our
other studies implying that USP4 promotes DSB repair viamech-
anisms distinct from its spliceosomal functions in concert with
SART3, HR was not significantly altered by SART3 depletion
(Figure S2D; see Figure S2C for siSART3 depletion).
In accordance with USP4 functioning in HR, its depletion
sensitized cells to camptothecin (Figure 2B), which yields repli-
cation-associated one-ended DSBs in S-phase that must be
repaired by HR. In HR, RAD51 assemblies replace replication
protein A (RPA) on resected ssDNA to form nucleoprotein fila-
ments that mediate strand-invasion and ensuing HR events. As
these RAD51 assemblies can be detected as IR-induced sub-
nuclear foci (IRIF) (Polo and Jackson, 2011), we assessedcular Cell 60, 362–373, November 5, 2015 ª2015 The Authors 363
Figure 1. USP4 Promotes DSB Repair
(A) USP4-targeting siRNAs depleted USP4 from U2OS cells.
(B) USP4 depletion from U2OS cells caused DSB repair defects (neutral comet assays) after phleomycin (40 mg/ml, 2 hr) treatment, measuring the effects of
depleting CtIP or DNA ligase IV, as controls (mean ± SEM; n = 3). Also see Table S1 for siRNAs and Table S2 for antibodies used in this study.
(C) Treatments of U2OS cells with USP4-2 but not USP4-UTR siRNAs depleted exogenously expressed GFP-USP4 WT(L); exog, exogenous; endog, endog-
enous. Also, see Table S3 for plasmids used in this study.
(D) Exogenously expressed USP4 WT(L) restored DSB repair defects (neutral comet assays) observed after USP4 depletion (mean ± SEM; n = 3).
(E) USP4 depletion sensitized U2OS cells to IR (mean ± SEM; n = 3 and XRCC4 siRNA-treated cells were the positive control).
(F) Treatment of U2OS cells with USP4-UTR siRNAs depleted endogenous USP4 but not exogenously expressed GFP-USP4 WT(H) or CD. exog, exogenous;
endog, endogenous (also see Figure S1C for expression levels).
(G) Expression of GFP-USP4 CD but not WT(H) caused DSB repair defects (neutral comet assays) irrespective of endogenous USP4 depletion (mean ±
SEM; n = 3).
(H) Expression of GFP-USP4 CD sensitized U2OS cells to IR (mean ± SEM; n = 3).
(I) GFP-USP4WT and CD immunoprecipitations from U2OS cell extracts retrieved FLAG-USP4WT (*p < 0.05 **p < 0.01; n.s., not significant). See also Figure S1.
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Figure 2. USP4 Functions in DNA-End Resection
(A) USP4 depletion caused HR defects [direct-repeat (DR)-GFP reporter assays]. Quantifications were normalized to control siRNA-treated cells and set to 100%
(mean ± SEM; n = 4).
(B) USP4 depletion sensitized U2OS cells to camptothecin (CPT) (mean ± SEM; n = 3 and CtIP siRNA-treatment was the positive control).
(C) USP4 depletion reduced RPA2 Ser-4/Ser-8 phosphorylation (S4S8p) after IR (10 Gy).
(D) USP4 depletion reduced RPA2 S4S8p after camptothecin (1 mM, 1 hr) treatment. Intensities were quantified with Odysey CLx (LI-COR) and Image Studio 4.x
software andRPA2 S4S8pwas normalized to RPA2. Quantifications were normalized to the camptothecin-treated siControl and set to 100% (mean ± SEM; n = 3).
(E) USP4 siRNA treatment, followed by camptothecin (1 mM, 1 hr) treatment, of U2OS cells reduced resection (BrdU intensities). Quantifications were normalized
to the camptothecin-treated siControl (CtIP depletion was the positive control; mean ± SEM; n = 3).
(F) GFP-USP4WT(L)-complemented U2OS cells restored resection defects (BrdU intensities) observed upon USP4 depletion. Quantifications were normalized to
camptothecin and Control siRNA-treated GFP cells (mean ± SEM; n = 3; *p < 0.05; **p < 0.01; ***p < 0.001; n.s., not significant). See also Figure S2.whether their formation was affected by USP4. Indeed, USP4
depletion reduced the proportion of cells exhibiting RAD51 foci
that co-localized with gH2AX, indicating that RAD51 loading at
DSB sites was compromised (Figure S2E; BRCA1 depletion
was used as control). When loaded on ssDNA, the RPA subunit
RPA2 is phosphorylated on Ser-4 and Ser-8, and inhibition
of all known DNA-end resection factors reduces this mark
(e.g., Gravel et al., 2008; Polo et al., 2012; Sartori et al., 2007).
In line with USP4 affecting resection, its depletion reduced
RPA2 Ser-4/Ser-8 phosphorylation (S4S8p) at various times
after IR (Figure 2C) or camptothecin exposure (Figures 2D and
S2F). Importantly, gH2AX intensities after camptothecin treat-
ment were not significantly affected when cells were treated
with the siRNA targeting the USP4 30 UTR (Figure S2F), implying
that S-phase entry and progression were not markedly altered
by USP4 depletion (siUSP4-2 treatments reduced S-phase
cell populations by 25% [Figure S2A], probably partially ac-
counting for reduced gH2AX and S4S8p RPA2 after siUSP4-2
treatment [Figure S2F]). We also found that expression of GFP-MoleUSP4 WT(L) at levels similar to those of endogenous USP4,
partially rescued the RPA2 phosphorylation defect caused by
depleting endogenous USP4 (Figure S2G). Furthermore, pulse-
labeling cells with 5-ethynyl-20-deoxyuridine (EdU) followed by
assessment of its incorporation into DNA using EdU labeling
indicated that overall levels of DNA replication in S-phase cells
were not significantly altered by USP4 depletion (Figure S2H).
Collectively, these data strongly suggested that USP4 promotes
DNA-end resection.
To more directly address resection efficiencies in S-phase cell
populations, we pulse-labeled cells with 5-bromo-20-deoxyuri-
dine (BrdU), treated them with camptothecin, and then probed
for BrdU incorporation under native conditions where BrdU is
detected in ssDNA but not dsDNA. Flow-cytometry-based
quantification established that USP4 depletion (Figure 2E), but
not SART3 depletion (Figure S2I), reduced native BrdU staining
intensities in replicating cells without USP4 or SART3 depletion
affecting protein levels of key resection factors (Figure S2J).
Furthermore, the resection defect caused by depletingcular Cell 60, 362–373, November 5, 2015 ª2015 The Authors 365
Figure 3. USP4 Regulates CtIP Recruitment to DNA Damage Sites
(A) NBS1 recruitment to laser-line micro-irradiation induced DNA lesions in Cyclin A-positive U2OS cells that were treated with USP4-targeting siRNAs was not
reduced compared to the siRNA control. Nuclei were outlined, and the scale bar indicated 10 mm.
(B) CtIP recruitment to laser-line micro-irradiation induced DNA lesions in Cyclin A-positive U2OS cells was reduced after USP4 siRNA treatments. RAD50 siRNA
treatment (see Figure S3A for RAD50 depletion) was the positive control (mean ± SEM; n = 3; **p < 0.01). Nuclei were outlined, and the scale bar indicated 10 mm.
See also Figure S3.endogenous USP4 was largely restored by GFP-USP4 WT(L)
expression (Figure 2F). Taken together, these data indicated
that, in a SART3-independent manner, USP4 promotes resec-
tion, thus at least in part explaining its impact on HR.
USP4 Regulates CtIP Recruitment to DNA Damage Sites
Because the MRN complex and CtIP play key roles in DSB
resection (Sartori et al., 2007), we assessedwhether their recruit-
ment to DNA damage sites was affected by USP4. We observed
that USP4 depletion did not detectably affect NBS1 (Figure 3A)
or MRE11 (data not shown) recruitment to DNA damage induced
by laser micro-irradiation. By contrast, CtIP recruitment to DNA
damage sites in gH2AX and Cyclin-A-positive cells was signifi-
cantly reduced upon USP4 depletion (Figure 3B; CtIP recruit-
ment was also impaired in RAD50-depleted cells; see Figure S3
for RAD50 depletion). These data thus implied that USP4 pro-
motes HR by affecting the recruitment and/or association dy-
namics of CtIP at DNA damage sites.
USP4 Interacts with CtIP and MRN via Its C-Terminal
Insert Region
In light of the above findings, we tested whether USP4 might
physically interact with CtIP and/or MRN. Indeed, when we
immunoprecipitated endogenous USP4 from human 293FT cell
extracts ensuing western blotting analyses readily detected
both RAD50 and MRE11 (Figure 4A). Despite it being well estab-
lished that CtIP interacts with MRN (e.g., Sartori et al., 2007;
Wang et al., 2013), we did not detect CtIP in our immunoprecip-
itates. In line with our speculation that this might reflect CtIP
interactions being disrupted/weakened by the anti-USP4 anti-
body, CtIP was detected together with RAD50 and MRE11 in
immunoprecipitates generated by using an anti-GFP antibody
and lysates from cells transiently expressing GFP-FLAG-fused
full-length (FL) USP4 (GFP-FLAG-USP4-FL; Figure 4B; GFP-366 Molecular Cell 60, 362–373, November 5, 2015 ª2015 The AuthoFLAG only expression was used as control. As shown in Fig-
ure S4A, these interactions were not discernibly affected by
DNA damage induction). Such interactions were also seen in
reciprocal studies where GFP-CtIP or GFP-FLAG-MRE11 was
immunoprecipitated and ensuing samples probed for endoge-
nous USP4 (Figures 4C and 4D, respectively).
To identify the region(s) of USP4mediating its MRN/CtIP inter-
actions, we expressed various USP4 deletion mutants in cells
(Figure 4E; Table S3), immunoprecipitated them, and then
probed for CtIP, RAD50, andMRE11 binding bywestern blotting.
This established that interactions with CtIP and MRN were not
diminished by deleting the USP4 ubiquitin-like domain 2 (UBL2)
region (DUBL2) or the N-terminal 30% of USP4 (DN). Further-
more, CtIP and MRN did not detectably interact with the UBL2
or N-terminal domain of USP4 (Figures 4E and S4B; data not
shown). These results thus indicated that USP4 interactions
with CtIP and the MRN complex likely occurred via the USP4
C-terminal catalytic region D1 and D2 domains and/or the C-ter-
minal insert region (I) positioned between these domains (Fig-
ure 4E). Focusing on the USP4 catalytic domain, which structur-
ally resembles an open right hand comprising three regions
named the ‘‘thumb’’ (T), ‘‘fingers’’ (F), and ‘‘palm’’ (P) catalytic
sub-domains (Clerici et al., 2014), we found that the USP4 ‘‘fin-
gers’’ domain including the insert (F+I), but not the other regions
tested, was sufficient to mediate interactions with CtIP, MRE11,
andRAD50 (Figures 4Eand4F; see FigureS4C for corresponding
inputs). Further analyses indicated that theUSP4 insert (I), but not
the fingers (F), regionwas sufficient for these interactions (Figures
4Eand4G; seeFigureS4D for inputs), althoughwenote that addi-
tional USP4 regions might also contribute to interactor binding.USP4 Counteracts Its Own Ubiquitylation
During the course of our studies, we observed that mutating
the USP4 catalytic cysteine to alanine (C311A) to render USP4rs
Figure 4. USP4 Interacts with CtIP and MRN via Its C-Terminal Insert Region
(A) Endogenous USP4 immunoprecipitation (IP) from 293FT cell extracts retrieved RAD50 and MRE11.
(B) Full-length (FL) GFP-FLAG-USP4 IP from U2OS cell lysates retrieved CtIP, RAD50, and MRE11.
(C and D) (C) GFP-FLAG-MRE11 or (D) GFP-CtIP immunoprecipitations from 293FT cell extracts retrieved USP4.
(E) Schematic view of full-length (FL) USP4 with indicated structural domains. USP4 deletion mutants and their ability to retrieve CtIP or MRN were indicated.
Positions of cysteine, histidine and aspartic-acid that form the USP4 catalytic triad; the zinc-binding motif cysteine residues (CysXXCys); and the ‘‘thumb,’’
‘‘fingers,’’ and ‘‘palm’’ catalytic subdomains were indicated.
(F) GFP-FLAG-USP4-F+I immunoprecipitations retrieved CtIP, RAD50, and MRE11 (See Figure S4C for corresponding inputs; all samples were run on the same
SDS-poly acrylamide gel).
(G) GFP-FLAG-USP4-I immunoprecipitations retrieved CtIP, RAD50, and MRE11 (See Figure S4D for inputs). See also Figure S4.enzymatically inactive (‘‘catalytic-dead’’ [CD]), almost totally
abrogated its interactions with CtIP and MRN (Figure 5A; note
that binding of USP4 to CtIP and RAD50 was not abrogated by
the DNA-intercalating agent ethidium bromide (EtBr), suggesting
that interaction was not mediated by DNA bridging. See Fig-
ure S5A for inputs). In light of previous work indicating that
USP4 can deubiquitylate itself (Wada et al., 2006), we hypothe-
sized that USP4 catalytic inactivation could lead to its enhanced
ubiquitylation, which might block its CtIP/MRN interactions. WeMoletherefore assessed ubiquitylation of GFP-USP4 WT, GFP-USP4
CD, and GFP (assessment of endogenous USP4 ubiquitylation
events could more directly address the physiological nature of
such modifications but was technically not feasible; data not
shown) by co-expressing these with human influenza hemagglu-
tinin-epitope-tagged ubiquitin (HA-Ub) and immunoprecipitating
ubiquitylated proteins with anHA antibody in the presence of 1M
NaCl. Western blotting of ensuing samples with a GFP antibody
indicated that HA-ubiquitin retrieved USP4 CD but not USP4WTcular Cell 60, 362–373, November 5, 2015 ª2015 The Authors 367
Figure 5. USP4 Counteracts Its Own Ubiq-
uitylation
(A) GFP-USP4 WT but not CD immunoprecipita-
tions from U2OS cell extracts retrieved CtIP and
RAD50 in presence or absence of EtBr (50 mg/ml;
see Figure S5A for inputs).
(B) HA-ubiquitin (HA-Ub) immunoprecipitations
(in presence of 1 M NaCl) retrieved GFP-USP4 CD
but no detectable GFP-USP4 WT from U2OS cell
extracts.
(C) GFP-immunoprecipitations from U2OS cell
extracts that expressed HA-ubiquitin and GFP,
GFP-USP4 WT, or CD, followed by western blot
analysis with an HA antibody retrieved HA-ubiq-
uitylated forms of GFP-USP4 CD and to a lesser
extent GFP-USP4 WT (130 or 250 indicated
respective protein sizes in kDa).
(D) HA-Ub immunoprecipitations from U2OS
cell extracts that were processed in absence of
b-mercaptoethanol (bME) retrieved modified
forms of GFP-USP4 CD that were not visible in
presence of bME (exp., exposure; GFP cells were
the control).
(E) GFP immunoprecipitations from U2OS cell
extracts that were processed in absence of bME,
retrieved modified forms of GFP-USP4 CD, and to
a lesser extent GFP-USP4 WT, which were not
visible in presence of bME.
(F) HA-Ub immunoprecipitations (followed by
western blotting analysis) from U2OS cell extracts
expressing various GFP-fused USP4 derivatives
retrieved GFP-USP4 CD and CD-C799A, but less
efficiently the other zinc-binding motif cysteine
mutants (CD-C461A, CD-C464A, and CD-C802A;
IgG, IgG heavy chain). All samples were run on the
sameSDS poly-acrylamide gel. See also Figure S5
and Table S4 (describes all ubiquitin sites identi-
fied by tandem mass spectrometry on USP4 WT
and CD).or GFP alone at appreciable levels (Figure 5B). Although these
results might have been explained by USP4 CD displaying
enhanced non-covalent binding to ubiquitin than wild-type
USP4, when we carried out binding studies with recombinant
ubiquitin, this was not the case (Figure S5B). To verify that
USP4 was indeed ubiquitylated, we prepared GFP-immuno-
precipitates from lysates of cells co-expressing HA-ubiquitin
together with GFP-USP4 WT or CD. Probing ensuing western
blots with an HA antibody detected smears of slower migrating
products, thus identifying these as ubiquitylated USP4 deriva-
tives (Figure 5C). Furthermore, in line with our other findings and
previously reported USP4 ubiquitylation events (Wada et al.,
2006), these ubiquitylated species were more prominent with
GFP-USP4 CD than with GFP-USP4 WT (Figure 5C). Together
with the stringency of the immunoprecipitation conditions we368 Molecular Cell 60, 362–373, November 5, 2015 ª2015 The Authorsused, these data indicated that USP4 is
ubiquitylated and that catalytically dead
USP4 contained greater levels of cova-
lently bound ubiquitin than the wild-type
protein.
To assess USP4 ubiquitylation further,
we carried out tandem mass spectrom-etry studies on GFP-USP4 CD or WT, purified from cell lysates
via GFP-immunoprecipitations, followed by post-translational
modification analysis to identify GlyGly modifications on amino
acid residues, representing remains of ubiquitin or ubiquitin-
like modifications after trypsin digestion. Thus, we detected
such modifications on a considerable number of lysine residues
and also on serine and threonine residues (see Table S4).
Notably, our analysis also suggested ubiquitylations on non-
conventional cysteine residues of both USP4 CD and WT. In
particular, we noted evidence for modifications on Cys-461 or
Cys-464 and Cys-799 or Cys-802 (Figures S5C and S5D; data
not shown; as each pair of cysteine residues was on the same
trypic peptide, it was not possible to differentiate between
them), which form a flexible zinc-binding region that stabilizes
the catalytic domain of USP4 (Clerici et al., 2014). Further
analysis and quantification of these ubiquitylations by mass
spectrometry was not possible however, due to technical is-
sues relating to the labile nature of ubiquitin-thioester linkages
(see below) and confounding modifications of these and other
USP4 cysteine residues by chemical reagents used in sample
preparations (see Supplemental Information for further details).
Previous reports have proposed the existence of ubiquitin ad-
ducts in which the ubiquitin C terminus is covalently attached to
target protein serine or threonine residues by ester linkages or
cysteine residues by thioester linkages (e.g., Cadwell and Co-
scoy, 2005). While cysteine ubiquitylation has so far been largely
unexplored, its prevalence may have been underestimated
because the associated thioester linkage is readily disrupted
by reducing agents (Huang et al., 2009) such as b-mercaptoe-
thanol that are often used in cell extract generation and analysis.
In light of this and our other data, we tested whether we could
detect USP4 ubiquitylations that were sensitive to b-mercaptoe-
thanol treatment. Thus, through HA-ubiquitin immunoprecipita-
tions followed by western blotting in the absence or presence
of b-mercaptoethanol, we identified modified forms of GFP-
USP4 CD that migrated more slowly on SDS polyacrylamide
gels than GFP-USP4 WT and which were lost upon b-mercap-
toethanol treatment (Figure 5D). To confirm this finding, we car-
ried out GFP immunoprecipitations from extracts containing
GFP-tagged USP4 CD or USP4 WT and processed these the
in absence or presence of b-mercaptoethanol. Western blot
analysis with an antibody recognizing GFP revealed that USP4
CD and to a lesser extent USP4WTweremodified and that these
modifications were not observed when samples had been
treated with b-mercaptoethanol (Figure 5E; note that USP4 WT
and CD were present in similar amounts and that it is unlikely
that the observed modifications reflected differential oxidation
events between wild-type and catalytically dead USP4). These
results indicated that at least a fraction of ubiquitylated USP4
CD was sensitive to reducing conditions, thus supporting the
conclusion that the protein is subject to cysteine ubiquitylation.
Structural data (Clerici et al., 2014) indicate that Cys-799,
-802, -461, and -464 form a flexible zinc-binding region that
stabilizes the USP4 catalytic domain and is exposed outward
from the protein core, potentially making the region acces-
sible for modification. While exploring the possible functional
impact of these cysteine residues, we found that USP4 CD de-
rivatives containing cysteine to alanine mutations on Cys-461
(C461A), Cys-464 (C464A), and Cys-802 (C802A) but not Cys-
799 (C799A) upon co-expression in cells with HA-ubiquitin,
were less readily retrieved by HA-ubiquitin immunoprecipi-
tations from cell extracts than the GFP-USP4 CD protein itself
(Figure 5F). While these findings provided support for the zinc-
binding motif cysteine residues being ubiquitylated, it is also
possible that mutating these sites altered USP4 structurally
in a manner that reduced its overall ubiquitylation levels,
perhaps by making it a less effective target for relevant E3
ubiquitin ligases. Nevertheless, as shown in Figure S5E, we
found that although binding of an HA-ubiquitin activity probe
was lower for USP4 WT-C464A than for USP4 WT, the Cys-
464 mutation still maintained catalytic activity, implying that
the USP4 structure was still at least in part intact. Together,
these findings supported a model in which USP4 ubiquityla-Moletions, including those on zinc-binding cysteine residues, are
subject to turnover by USP4 catalytic activity.
Ubiquitylation Counteracts USP4 Interactions and
Function
Our data highlighted how disrupting USP4 catalytic activity
abrogated its interactions with CtIP and MRN and also led to
enhanced USP4 ubiquitylation, suggesting that these phenom-
ena might be mechanistically linked. To address this possibility,
we focused onUSP4Cys-464, whosemutation strongly reduced
retrieval of USP4 CD by HA-ubiquitin immunoprecipitations.
Thus, we carried out immunoprecipitation-western blot analyses
to see whether introducing the Cys-464 to Ala (C464A) mutation
into USP4CD (in which the USP4 catalytic cysteine residue C311
was mutated to alanine) might restore interactions with CtIP
and MRN. Indeed, while having little or no effect on CtIP/MRN
interactions with GFP-USP4 WT, the C464A mutation markedly
stimulated interactions between GFP-USP4 CD and CtIP/MRN
(Figure 6A; see Figure S6 for corresponding inputs). To explore
whether this compensatory effect extended to USP4 functions
in the DDR, we generated U2OS cell lines stably expressing
GFP-USP4WT-C464A or GFP-USP4CD-C464A (Figure 6B). An-
alyses of these and the previously described GFP-USP4 WT(H)
and CD cell lines established that mutating the USP4 catalytic
cysteine to alanine resulted in CtIP recruitment and resection de-
fects that were largely alleviated by the C464A mutation (Figures
6C and 6D, respectively). These results thus supported a model
in which USP4 functions primarily throughmediating interactions
with CtIP and theMRN complex rather than by targeting these or
other factors for deubiquitylation.
As we had previously found that expression of USP4 CD
functioned in a dominant-negative manner (Figure 1G and Fig-
ure S1F), we assessed whether this was abrogated by the
C464A mutation. Indeed, neutral comet assays indicated that
GFP-USP4 CD but not GFP-USP4 CD-C464A expression
caused DSB repair defects in cells after phleomycin treatment
(Figure 6E). Importantly, GFP-USP4 CD but not GFP-USP4
CD-C464A expression also caused DSB repair defects when
endogenous USP4 was depleted from cells by siRNA treatment
(Figure 6F), establishing that GFP-USP4 CD-C464A functions
directly to promote DSB repair without endogenous USP4
contributing to the phenotype. Together, these findings provided
support for USP4 interactions with CtIP/MRN being critical for its
DDR functions and for amodel wherein USP4 auto-deubiquityla-
tion promotes these interactions and thereby USP4 functions in
DSB repair.
Auto-Regulated Ubiquitylation of Other USP-Family
DUBs
Based on the above findings, we hypothesized that, like USP4,
other USP-family DUBs might be subject to ubiquitylation to
regulate protein interactions in a manner counteracted by their
catalytic activities. Focusing on USP15 and USP11, the two
DUBs most related to USP4, we rendered them catalytically
inactive by mutating their catalytic cysteine residue to alanine
(USP15 C298A and USP11 C318A; see Figure S7A for sequence
alignments). Strikingly, co-expression of these or wild-type ver-
sions with HA-ubiquitin followed by immunoprecipitations withcular Cell 60, 362–373, November 5, 2015 ª2015 The Authors 369
Figure 6. Ubiquitylation Counteracts USP4
Interactions and Function
(A) GFP-USP4WT,WT-C464A, andCD-C464A but
not CD immunoprecipitations retrieved CtIP,
RAD50, and MRE11 (see Figure S5A for inputs).
(B) Protein levels of U2OS cells expressing GFP-
USP4 WT-C464A or GFP-USP4 CD-C464A. GFP,
GFP-USP4 WT (H) and CD cell lines were
described previously (Figure S1C).
(C–E) Mutating USP4 Cys-464 to Ala restored (C)
CtIP recruitment defects (mean ± SEM; n = 3), (D)
DNA-end resection defects (mean ± SEM; n = 5),
and (E) DSB repair (neutral comet assays) defects
(mean ± SEM; n = 3), observed with GFP-USP4
CD-expressing U2OS cells.
(F) Mutating Cys-464 to an alanine in USP4-UTR
siRNA-treated U2OS cells restored the DSB repair
defects observed in GFP-USP4 CD expressing
cells upon endogenous USP4 depletion (mean ±
SEM; n = 3; *p < 0.05; **p < 0.01). See also Fig-
ure S6.an HA antibody and western blot analysis under reducing condi-
tions revealed that USP15 CD and USP11 CD were retrieved
more strongly than their corresponding wild-type proteins
(Figure 7A). Furthermore, as for USP4 CD, when samples were
analyzed under non-reducing conditions, USP15 CD and
USP11 CD exhibited additional slower-migrating species (Fig-
ure 7B). These findings thus suggested that, as for USP4, the
catalytic activities of USP15 and USP11 counteract their respec-
tive ubiquitin modifications. To investigate USP15 further, we
focused on USP15 Cys-451, which forms part of the USP15
zinc-binding motif and aligns with USP4 Cys-464, whose muta-
tion to alanine reduced the ability of USP4 CD to be retrieved by
HA-ubiquitin under stringent immunoprecipitation conditions
(see Figure 5D). Notably, transient co-expression studies em-
ploying HA-ubiquitin and various USP15 derivatives followed
by HA immunoprecipitation-western blotting indicated that intro-
ducing the C451A mutation reduced the amount of GFP-USP15
CD recovered with HA-ubiquitin (Figure 7C). In light of our USP4
findings, we tested whether catalytically dead USP15 was still
able to interact with one of its established substrates, SMAD2/
3 (Inui et al., 2011), and if this interaction was influenced by
C451A mutagenesis. Thus, through immunoprecipitation-west-
ern blot analyses, we found that, unlike USP15 WT, USP15 CD
was impaired in its ability to interact with SMAD2/3 and that
the USP15 CD-C451A mutant restored this interaction (Fig-
ure 7D; see Figure S7B for inputs). These findings thereby sup-370 Molecular Cell 60, 362–373, November 5, 2015 ª2015 The Authorsported a model in which, as for USP4,
USP15 catalytic activity counteracts its
own ubiquitylation to promote substrate
interactions.
DISCUSSION
We have established that USP4 pro-
motes DSB repair by HR and cellular
resistance to IR and the topoisomerase
I inhibitor camptothecin. Mechanistically,we found that USP4 does so at least in part by promoting DSB
resection in a manner that appears to be independent of its es-
tablished spliceosomal functions. Accordingly, we established
that USP4-depleted cells display defects in DNA-damage-
induced RPA2 phosphorylation and in RAD51 accumulation at
DNA damage sites. Moreover, we found that USP4 depletion
markedly impaired DNA-damage accumulation of the DNA-
end resection factor CtIP. USP4 thus joins a growing number
of proteins known to affect CtIP activity, highlighting the crucial
importance of appropriately controlling and regulating the initia-
tion of resection.
By assessing the properties of USP4 derivatives, we discov-
ered that it directly or indirectly interacts with CtIP and MRN
and that the USP4 insert region, which resides between the
USP4D1 andD2 catalytic subdomains, was sufficient tomediate
such interactions. Moreover, we observed that inactivating
USP4 catalytic function almost totally abrogated its CtIP/MRN
interactions. Through exploring the mechanism of this effect,
we found that catalytically inactive USP4 was retrieved more
effectively by HA-tagged ubiquitin than the wild-type USP4 pro-
tein, leading us to investigate whether its CtIP/MRN interactions
might be affected by USP4 auto-deubiquitylation. Indeed, by
mass-spectrometry, we identified various USP4 ubiquitylations
that were enhanced upon USP4 catalytic inactivation, including
those on cysteine residues within an evolutionarily conserved
USP4 zinc-binding motif. Consistent with the chemical nature
Figure 7. Auto-Regulated Ubiquitylation of Other USP-Family DUBs
(A) HA-ubiquitin (HA-Ub) immunoprecipitations (in presence of bME) retrieved
USP4 CD, USP15 CD, and USP11 CD (wild-type USP4, USP15, and USP11
were not or weakly detected under these conditions).
(B) HA-Ub immunoprecipitations from U2OS cell extracts that were processed
without bME retrievedmodified forms of USP4 CD, USP15 CD, and USP11 CD
(exp., exposure).
(C) HA-Ub immunoprecipitations from U2OS cell extracts retrieved USP15
CD-C451A less efficiently than USP15 CD.
(D) USP15 WT, WT-C451A, and CD-C451A but not CD immunoprecipitations
from U2OS cell extracts (see Figure S7B for inputs) efficiently retrieved
SMAD2/3. See also Figure S7.of these ubiquitin thioester linkages, our ensuing studies high-
lighted their removal by b-mercaptoethanol. Moreover, mutating
such cysteine residues to alanine prevented USP4 retrieval by
HA-ubiquitin, restored the ability of catalytically dead USP4 to
interact with CtIP/MRN, and also restored the ability of catalyt-
ically inactive USP4 to promote DSB repair, even in the
absence of endogenous USP4. Taken together, our observa-
tions support a model in which USP4 is subject to ubiquitylation
in a manner that interferes with CtIP and MRN binding, thus im-
pairing resection and abrogating HR. Moreover, our results
indicate that the key DDR role for USP4 catalytic function is
to counteract modifications on itself, thereby promoting CtIP/
MRN binding, resection, and HR. Additional biochemical ana-
lyses will be needed to address precisely how USP4 ubiquity-
lations inhibit its interactions with other proteins. One possibility
is that ubiquitylation competes with ubiquitin that is retained by
the USP4 ubiquitin-binding pocket and switching-loop motif,
following substrate hydrolysis (Clerici et al., 2014; Sahtoe and
Sixma, 2015). It remains to be established which ubiquitin li-
gase(s) mediate(s) USP4 ubiquitylation and whether the auto-Moleregulatory paradigm we have established is constitutive or is
affected by factors such as cell-cycle status, chromatin struc-
ture, or DDR signaling.
In contrast to the extensive literature on lysine ubiquitylation,
few reports have described ubiquitylation of cysteine residues
(e.g., Cadwell and Coscoy, 2005) other than on E1-activating
enzymes, E2-conjugating enzymes, and HECT-domain E3
ubiquitin ligases (Komander, 2009a). Our mapping of USP4
cysteine ubiquitylations and our observation that such ubiqui-
tylations are labile under reducing conditions, highlight how
cysteine ubiquitylation and deubiquitylation might occur more
generally, at least within the USP-DUB ubiquitin protease
family, many of which contain zinc-binding cysteine motifs
(Ye et al., 2009). Furthermore, we found that, as for USP4,
USP15 and USP11 catalytic inactivation led to the accumula-
tion of modified forms that were abrogated by reducing agents
and that mutating Cys-451 of USP15, which aligns with USP4
Cys-464, reduced USP15 retrieval by HA-ubiquitin. Moreover,
we established that, analogously to USP4, catalytically inactive
USP15 was impaired in binding to its protein target, SMAD2/3,
and that binding was restored by introducing the Cys-451 mu-
tation. In light of the phylogenetic connections between USP4,
USP15, and USP11, and because both USP4 (this study) and
USP11 function in DNA repair (Schoenfeld et al., 2004; Wilt-
shire et al., 2010), it will be of interest to explore possible
DDR roles for USP15. In this regard, we note that USP15 has
been identified as a target for ATM-mediated phosphorylation
(Mu et al., 2007) and mediates resistance to IR (Nishi et al.,
2014) and that like USP4, USP11 and USP15 are recruited to
sites of laser-induced DNA damage (Nishi et al., 2014). Finally,
if small-molecule inhibitors of USP4, USP15, and/or USP11 are
developed, it will be interesting to pursue their potential in can-
cer therapy.EXPERIMENTAL PROCEDURES
For detailed descriptions of these and additional procedures, see Supple-
mental Experimental Procedures.
Cells, Cell Lines and Growth Conditions
U2OS cells were cultured under conventional growth conditions. All stable
cells lines exogenously expressing GFP or FLAG-fused USP4 and mutant de-
rivatives and 293FT cells were cultured in presence of 0.5mg/ml geneticin (Life
technologies). DR-GFP expressing U2OS cells were cultured in presence of
1 mg/ml puromycin.
Antibodies, SDS-PAGE, and Western Blot Analysis
See Table S2 for antibodies used in this study. SDS-PAGE and western blot
analyses were performed as described previously (Nishi et al., 2014).
siRNAs, Plasmids, and Transfections
See Table S1s and S3 for respective siRNAs and plasmids described in this
study. Plasmids were transfected using TransIT-LT1 (Mirus Bio) transfection
reagent according to the manufacturer’s instructions, and siRNA transfections
(30 nM/transfection) were carried out using Hiperfect (QIAGEN) according to
the manufacturer’s instructions.
Neutral Comet and Clonogenic Cell Survival Assays
Neutral comet and clonogenic cell survival assays were performed as previ-
ously described (Nishi et al., 2014).cular Cell 60, 362–373, November 5, 2015 ª2015 The Authors 371
Immunoprecipitations
Immunoprecipitation experiments from U2OS or 293FT cells were performed
as previously described (Blackford et al., 2015).
Live Cell Laser-Line Micro-Irradiation
GFP-USP4 WT(H)-expressing cells were BrdU sensitized and then sub-
jected to 400 mW localized laser micro-irradiation with a 405 nm UVA laser
beam (Limoli et al., 1993). Pictures were taken before and 30 min after
irradiation.
DR-GFP HR Reporter Assays
HR reporter assays were performed as previously described (Nishi et al.,
2014).
DNA-End Resection (BrdU) Assay
BrdU pulse-labeled U2OS cells were treated with 1 mM camptothecin, pro-
cessed, and treated with BrdU and gH2AX primary and secondary antibodies
(Table S2). Cells were analyzed by flow cytometry with gH2AX detection as a
control for DNA damage.
Cell Cycle Analysis and Random Plasmid Integration Assays
Cell cycle analyses and random plasmid integration assays to measure NHEJ
efficiencies were performed as described previously (Nishi et al., 2014).
RAD51 IRIF
Cells were treatedwith IR (5Gy), allowed to recover for 8 hr, andwere fixed and
treated with RAD51 and gH2AX primary and secondary antibodies. gH2AX-
positive cells with more than three RAD51 foci were scored.
Click-it EDU Labeling
U2OS cells were EdU pulse-labeled and fixed. EdU labeling reactions were
performed using Click-iT according to themanufacturer’s instructions (Thermo
Fisher Scientific). EdU intensities of S-phase cell populations were measured
and quantified.
NBS1 or CtIP Recruitment to Laser-Line Micro-Irradiation Induced
DNA Lesions
U2OS cells were treated with BrdU (10 mM) for 24 hr, subjected to 250 mW
localized laser micro-irradiation with a 405 nm UV-A laser beam, and 2 hr after
irradiation were fixed and processed. Cyclin A, gH2AX, and NBS1- or CtIP-
positive cells were quantified.
Mass Spectrometry and Data Analysis
Samples were analyzed using nano liquid chromatography-tandem mass
spectrometry (nano-LC-MS/MS) in HCD mode as described previously
(Fischer and Kessler, 2015). Raw MS data were processed and analyzed
by PEAKS Version 7 (Bioinformatics Solutions) using HCD fragmentation
spectra. MS/MS spectra were searched against the Swissprot (21,039 human
sequence entries) database allowing for variable post-translational modifica-
tions to be applied to the de novo identified peptides. See Table S4 for identi-
fied ubiquitylations on USP4 WT and CD upon immunoprecipitation with a
GFP antibody from 293FT lysates. Amino acids in bold indicate previously
described USP4 ubiquitylations.
Ubiquitylation Assays
U2OS cells were co-transfected with HA-ubiquitin and GFP-tagged
expression constructs. Lysates were immunoprecipitated 48 hr later with
an HA antibody, and HA-retrieved proteins were subjected to western
blot analysis.
Biotin-Ubiquitin Binding Assay
StreptavidinM-280Dynabeads (Life Technologies) were soaked in an excess of
Biotin-fused human recombinant ubiquitin (R&DSystems) for 1 hr at 4C. Then,
cell lysateswere incubated for 16hr at4C inpresenceof10ml ubiquitin-coupled
streptavidin Dynabeads, after which those were washed, processed, and sub-
jected to western blot analysis as described in the Supplemental Experimental
Procedures.372 Molecular Cell 60, 362–373, November 5, 2015 ª2015 The AuthoActive Probe Binding Assays
Cells transfectedwith GFP, GFP-fused USP4WT, CD, orWT-C464Awere pro-
cessed; incubated with HA-tagged ubiquitin vinyl sulfone (HA-Ub-VS) accord-
ing to the manufacturer’s (Enzo Life Sciences) instructions; and subjected to
western blot analysis.
Statistics and Quantitative Analysis
For experiments reproduced at least three times in this study, the standard two-
tailed Student’s t test for statistical significance was used. For quantita-
tiveanalysis, theSEMwasused.All experimentswere reproducedat least twice.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, four tables, and Supple-
mental Experimental Procedures and can be found with this article online at
http://dx.doi.org/10.1016/j.molcel.2015.09.019.
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